Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
James Udelson MD
James E. Udelson MD Advisory Board
Deepak Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak L. Bhatt MD, MPH, FACC, FAHA, FESC, MSCAI Advisory Board
Benjamin Scirica MD
Benjamin Morgan Scirica MD Associate Editor
See All Experts
featured
Published in Cardiology and
1 other channel

Journal Scan / Research · April 01, 2019

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Prior Myocardial Infarction

Circulation

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Benjamin Scirica MD

Circulation
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Prior Myocardial Infarction: A Sub-Analysis From DECLARE TIMI-58 Trial
Circulation 2019 Mar 18;[EPub Ahead of Print], RHM Furtado, MP Bonaca, I Raz, TA Zelniker, O Mosenzon, A Cahn, J Kuder, SA Murphy, DL Bhatt, LA Leiter, DK McGuire, JPH Wilding, CT Ruff, JC Nicolau, IAM Gause-Nilsson, M Fredriksson, AM Langkilde, MS Sabatine, SD Wiviott

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated